TCHP and malignant colon neoplasm: HCT-116 (Fig. 6A–B) and HT-29 (Fig. 6C–D and Fig. S16) demonstrate that VTD can significantly suppress colon cancer cell migration regardless of p53 tumor suppressor protein status.